Overestimation of Late Distant Recurrences in High-Risk Patients With ER-Positive Breast Cancer
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Journal of Clinical Oncology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Overestimation of Late Distant Recurrences in High-Risk Patients With ER-Positive Breast Cancer: Validity and Accuracy of the CTS5 Risk Score in the TEAM and IDEAL Trials
J. Clin. Oncol 2020 Jul 24;[EPub Ahead of Print], I Noordhoek, EJ Blok, E Meershoek-Klein Kranenbarg, H Putter, M Duijm-de Carpentier, EJT Rutgers, C Seynaeve, JMS Bartlett, JM Vannetzel, DW Rea, A Hasenburg, R Paridaens, CJ Markopoulos, Y Hozumi, JEA Portielje, JR Kroep, CJH van de Velde, GJ LiefersFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.